Suchen
Enovis Corp
ENOVZur Watchlist hinzufügen
24.290USD
-1.820-6.97%
Handelsschluss 05/15, 16:00（ET）Kurse um 15 Minuten verzögert
1.40BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Enovis Corp Unternehmen
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Enovis Corp Informationen
BörsenkürzelENOV
Name des UnternehmensEnovis Corp
IPO-datumMay 08, 2008
CEOMcdonald (Damien)
Anzahl der mitarbeiter7367
WertpapierartOrdinary Share
GeschäftsjahresendeMay 08
Addresse2711 Centerville Road
StadtWILMINGTON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl19808
Telefon13022529160
Websitehttps://www.enovis.com/
BörsenkürzelENOV
IPO-datumMay 08, 2008
CEOMcdonald (Damien)
Führungskräfte von Enovis Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
32.60K
+13.31%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
18.11K
-12.48%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
13.01K
-17.38%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
9.03K
-16.51%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
8.26K
-27.37%
Mr. A. Clayton Perfall
Mr. A. Clayton Perfall
Independent Director
Independent Director
--
--
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
32.60K
+13.31%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
18.11K
-12.48%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
13.01K
-17.38%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
9.03K
-16.51%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Medical Technology-Prevention & Rehabilitation
1.14B
50.58%
Medical Technology-Reconstructive
1.11B
49.42%
Nach RegionUSD
Name
Umsatz
Anteil
United States
1.30B
57.62%
Other Foreign locations
952.72M
42.38%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Medical Technology-Prevention & Rehabilitation
1.14B
50.58%
Medical Technology-Reconstructive
1.11B
49.42%
Aktionärsstatistik
Aktualisiert: Thu, May 14
Aktualisiert: Thu, May 14
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
14.02%
American Century Investment Management, Inc.
9.14%
Vanguard Portfolio Management, LLC
6.62%
Vanguard Capital Management, LLC
4.43%
Dimensional Fund Advisors, L.P.
4.42%
Andere
61.37%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
14.02%
American Century Investment Management, Inc.
9.14%
Vanguard Portfolio Management, LLC
6.62%
Vanguard Capital Management, LLC
4.43%
Dimensional Fund Advisors, L.P.
4.42%
Andere
61.37%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
66.66%
Investment Advisor/Hedge Fund
28.44%
Hedge Fund
17.41%
Research Firm
5.91%
Individual Investor
1.53%
Bank and Trust
1.19%
Pension Fund
1.14%
Venture Capital
0.04%
Insurance Company
0.03%
Institutionelle Beteiligung
Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
652
68.97M
119.81%
-6.76M
2025Q4
617
68.12M
125.63%
--
2025Q3
641
68.12M
128.26%
-1.19M
2025Q2
651
69.44M
130.24%
+2.07M
2025Q1
629
67.38M
125.09%
-4.06M
2024Q4
625
63.48M
125.04%
+1.28M
2024Q3
599
62.09M
124.13%
-57.94K
2024Q2
602
61.71M
121.92%
+2.05M
2024Q1
635
59.58M
125.47%
-9.23M
2023Q4
647
58.62M
120.02%
+2.97M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
8.07M
14.1%
+110.96K
+1.39%
Dec 31, 2025
American Century Investment Management, Inc.
5.26M
9.19%
+528.25K
+11.17%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.78M
4.86%
-189.61K
-6.38%
Dec 31, 2025
Rubric Capital Management LP
2.45M
4.29%
-296.74K
-10.79%
Dec 31, 2025
Davenport Asset Management
2.44M
4.26%
-367.69K
-13.10%
Dec 31, 2025
State Street Investment Management (US)
2.37M
4.14%
+20.61K
+0.88%
Dec 31, 2025
Dorsey Asset Management LLC
2.28M
3.98%
-120.12K
-5.01%
Dec 31, 2025
Fidelity Management & Research Company LLC
1.93M
3.37%
+665.45K
+52.61%
Dec 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
State Street SPDR S&P Health Care Equipment ETF
1.83%
Invesco S&P SmallCap Health Care ETF
1.09%
Invesco S&P SmallCap 600 Pure Value ETF
0.45%
State Street SPDR S&P 600 Small Cap Value ETF
0.25%
iShares S&P Small-Cap 600 Value ETF
0.24%
iShares U.S. Medical Devices ETF
0.21%
Humankind US Stock ETF
0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
0.18%
Avantis US Small Cap Equity ETF
0.18%
Invesco S&P SmallCap 600 Revenue ETF
0.16%
Mehr Anzeigen
State Street SPDR S&P Health Care Equipment ETF
Anteil1.83%
Invesco S&P SmallCap Health Care ETF
Anteil1.09%
Invesco S&P SmallCap 600 Pure Value ETF
Anteil0.45%
State Street SPDR S&P 600 Small Cap Value ETF
Anteil0.25%
iShares S&P Small-Cap 600 Value ETF
Anteil0.24%
iShares U.S. Medical Devices ETF
Anteil0.21%
Humankind US Stock ETF
Anteil0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
Anteil0.18%
Avantis US Small Cap Equity ETF
Anteil0.18%
Invesco S&P SmallCap 600 Revenue ETF
Anteil0.16%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Datum
Ex-Dividendentag
Art
Verhältnis
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
